Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma.

Grupp, S A; Stern, J W; Bunin, N; Nancarrow, C; Ross, A A; Mogul, M; Adams, R; Grier, H E; Gorlin, J B; Shamberger, R; Marcus, K; Neuberg, D; Weinstein, H J; Diller, L

Grupp, S A; Stern, J W; Bunin, N; Nancarrow, C; Ross, A A; Mogul, M; Adams, R; Grier, H E; Gorlin, J B; Shamberger, R; Marcus, K; Neuberg, D; Weinstein, H J; Diller, L.

Affiliation

Grupp SA; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, School of Medicine, Philadelphia, PA 19104, USA. grupp@email.chop.edu

J Clin Oncol ; 18(13): 2567-75, 2000 Jul.

Article in En | MEDLINE | ID: mdl-10893288

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Hematopoietic Stem Cell Transplantation; Neuroblastoma/therapy; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Blood Component Removal; Child; Child, Preschool; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation/adverse effects; Humans; Infant; Male

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Hematopoietic Stem Cell Transplantation / Neuroblastoma Type of study: Etiology_studies / Risk_factors_studies Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: J Clin Oncol Year: 2000 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links